Subscribe to RSS

DOI: 10.1055/a-2530-5965
Subependymal Giant Cell Astrocytoma in an Adult without Tuberous Sclerosis: Systematic Review and Illustrative Case Example

Abstract
Background Subependymal giant cell astrocytoma (SEGA) is a rare neoplasm arising from subependymal tissue. Predominantly associated with the tuberous sclerosis complex (TSC), SEGA may present with a range of diverse symptoms, most commonly seizures or neurocutaneous features of TSC. We present a novel case of sporadic SEGA in a 59-year-old woman who presented with acute intraparenchymal hemorrhage (IPH).
Methods Systematic literature review and illustrative case example.
Results A 59-year-old woman presented with a headache decreased level of consciousness, and acute IPH involving the anterior septum pellucidum and right medial caudate head. MRI was concerning for an underlying neoplasm, which grew slowly on follow-up imaging, prompting microsurgical resection. A gross total resection was achieved, and postoperative pathology confirmed SEGA (WHO grade I) without TSC1/2 mutation. She remained disease-free and neurologically intact at 1-year follow-up. A systematic review identified seven publications that revealed pathologically confirmed SEGA in nine adult patients without TSC. Headache, papilledema, and visual disturbances were the most common presenting symptoms. Treatment protocols included microsurgical resection versus biopsy followed by radiographic surveillance, and the overall rate of symptom-free survival was at least 80% as of the last follow-up.
Conclusion We report the tenth case of sporadic SEGA in an adult patient without TSC, as well as an associated systematic review of this rare neoplastic entity. Further study is required to identify risk factors for the development of sporadic SEGA, as well as potential avenues for the management of this disease that may depart from the standard protocol in pediatric TSC patients.
Publication History
Received: 24 September 2024
Accepted: 27 December 2024
Accepted Manuscript online:
03 February 2025
Article published online:
27 February 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Peron A, Au KS, Northrup H. Genetics, genomics, and genotype-phenotype correlations of TSC: insights for clinical practice. Am J Med Genet C Semin Med Genet 2018; 178 (03) 281-290
- 2 Kingswood C, Bolton P, Crawford P. et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Eur J Paediatr Neurol 2016; 20 (02) 296-308
- 3 Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers 2016; 2 (01) 16035
- 4 Zhang B, McDaniel SS, Rensing NR, Wong M. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One 2013; 8 (02) e57445-e57445
- 5 Gomes I, Jesus Ribeiro J, Palavra F. Monitoring and managing patients with tuberous sclerosis complex: current state of knowledge. J Multidiscip Healthc 2022; 15: 1469-1480
- 6 Stavrinou P, Spiliotopoulos A, Patsalas I. et al. Subependymal giant cell astrocytoma with intratumoral hemorrhage in the absence of tuberous sclerosis. J Clin Neurosci 2008; 15 (06) 704-706
- 7 Konakondla S, Jayarao M, Skrade J, Giannini C, Workman MJ, Morgan CJ. Subependymal giant cell astrocytoma in a genetically negative tuberous sclerosis complex adult: case report. Clin Neurol Neurosurg 2016; 150: 177-180
- 8 Palsgrove DN, Brosnan-Cashman JA, Giannini C. et al. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Mod Pathol 2018; 31 (12) 1787-1800
- 9 Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol 1996; 91 (04) 368-375
- 10 Jansen AC, Belousova E, Benedik MP. et al. Clinical characteristics of subependymal giant cell astrocytoma in tuberous sclerosis complex. Front Neurol 2019; 10: 705
- 11 Shelley I, Mahtabfar A, Farrell CJ. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case. J Neurosurg Case Lessons 2023 Jun 19; 5 (25) CASE23192
- 12 Li WQ, Li YM, Lu YC, Yu HY. Bulky subependymal giant cell astrocytoma with profuse blood supply without tuberous sclerosis. Neurosciences (Riyadh) 2010 Oct; 15 (4) 287-288
- 13 Macdonald DR, MacDonald MJ, Megyesi JF, Hammond RR. P09.03 Subependymal giant cell astrocytoma (SEGA) in adults without tuberous sclerosis. Neuro Oncol 2016; 18 (Suppl. 4) iv60
- 14 Takei H, Adesina AM, Powell SZ. Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex. Neuropathology 2009 Apr; 29 (2) 181-186
- 15 Kashiwagi N, Yoshihara W, Shimada N, Tanaka H, Fujita N. et al. Solitary subependymal giant cell astrocytoma: case report. Eur J Radiol 2000 Jan; 33 (1) 55-58